Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion type Assertion NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_head.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion description "[Cumulatively, these results suggest that all the enhanceosome components comprising ER?, FOXA1, and GATA3 are necessary for the full repertoire of cancer-associated effects of the ER?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_provenance.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion evidence source_evidence_literature NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_provenance.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion SIO_000772 21878914 NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_provenance.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion wasDerivedFrom befree-20140225 NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_provenance.
- NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_assertion wasGeneratedBy ECO_0000203 NP568070.RAVCUtcT-9KUFx1GoqUaTkqch0AXnGQW6QJVmcH3G4-JQ130_provenance.